Dingqian Hao

机构：Shandong University, Shandong Provincial Hospital, Liaocheng People's Hospital · ORCID：0000-0001-5789-1033

发表论文 13 篇 · 总被引 108 次 · h-index 6

代表论文

• miR‐200a‐3p regulates epithelial–mesenchymal transition and inflammation in chronic rhinosinusitis with nasal polyps by targeting ZEB1 via ERK/p38 pathway (2023 · International Forum of Allergy & Rhinology · 被引 27)
• The multifaceted mechanisms of Dihydrotanshinone I in the treatment of tumors (2024 · Biomedicine & Pharmacotherapy · 被引 18)
• Research progress of traditional Chinese medicine in the treatment of allergic rhinitis (2024 · Heliyon · 被引 17)
• An Integrated Analysis of Inflammatory Endotypes and Clinical Characteristics in Chronic Rhinosinusitis with Nasal Polyps (2022 · Journal of Inflammation Research · 被引 17)
• LRRC8A drives NADPH oxidase-mediated mitochondrial dysfunction and inflammation in allergic rhinitis (2024 · Journal of Translational Medicine · 被引 12)
• Piezo1-Induced Nasal Epithelial Barrier Dysfunction in Allergic Rhinitis (2025 · Inflammation · 被引 9)